| |
| |
|
| Insider
Information: |
Orbimed Capital Llc |
| Relationship: |
Director, 10% Owner |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
39,063,801 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$85,369,937 |
|
|
| Total
Shares |
39,063,801 |
|
|
| Total
Value |
$85,369,937 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-2.0
|
| Percentage
Gain/Loss : |
 -31.6%
|
-98.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Orthovita Inc |
VITA |
10% Owner |
2003-07-22 |
0 |
2004-01-14 |
5,350,000 |
Premium* |
|
|
American Cryostem Corporation |
CRYO |
10% Owner |
2007-06-14 |
0 |
2007-06-14 |
389,432 |
Premium* |
|
|
Alector, Inc. |
ALEC |
10% Owner |
2019-02-11 |
0 |
2020-03-02 |
0 |
Premium* |
|
|
Sierra Oncology Inc |
SRRA |
Director, 10% Owner |
2020-01-29 |
0 |
2020-01-29 |
1,477,320 |
Premium* |
|
|
Repare Therapeutics Inc. |
RPTX |
Director |
2020-06-23 |
0 |
2021-09-07 |
96,190 |
Premium* |
|
|
Fusion Pharmaceuticals Inc. |
FUSN |
Director |
2020-06-30 |
0 |
2020-06-30 |
192,100 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
Director, 10% Owner |
2020-09-25 |
0 |
2023-05-22 |
10,646,056 |
Premium* |
|
|
Pmv Pharmaceuticals, Inc. |
PMVP |
10% Owner |
2020-09-29 |
0 |
2022-03-31 |
6,589,330 |
Premium* |
|
|
Kinnate Biopharma Inc. |
KNTE |
Director, 10% Owner |
2020-12-02 |
0 |
2024-04-03 |
0 |
Premium* |
|
|
Silverback Therapeutics, Inc. |
SBTX |
Director |
2020-12-08 |
0 |
2023-08-29 |
9,240,887 |
Premium* |
|
|
Decibel Therapeutics, Inc. |
DBTX |
Director, 10% Owner |
2021-02-17 |
0 |
2021-02-17 |
883,418 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
Director, 10% Owner |
2021-07-16 |
0 |
2021-07-16 |
4,199,068 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALEC |
Alector, Inc. |
Director |
– • • |
2019-02-11 |
4 |
B |
$19.00 |
$7,822,300 |
I/I |
411,700 |
203,200 |
2.25 |
- |
|
| ALEC |
Alector, Inc. |
Director |
– • • |
2019-02-11 |
4 |
A |
$0.00 |
$0 |
I/I |
12,682,329 |
2,405,292 |
0 |
- |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2019-08-07 |
4 |
S |
$17.90 |
$11,635,000 |
I/I |
(650,000) |
2,968,604 |
0 |
- |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2019-12-17 |
4 |
S |
$18.52 |
$17,669,932 |
I/I |
(954,100) |
97,700 |
0 |
- |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2019-12-20 |
4 |
S |
$19.66 |
$6,733,550 |
I/I |
(342,500) |
59,800 |
0 |
- |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2019-12-23 |
4 |
S |
$19.82 |
$1,868,729 |
I/I |
(94,285) |
49,400 |
0 |
- |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2019-12-24 |
4 |
S |
$19.59 |
$1,406,562 |
I/I |
(71,800) |
41,400 |
0 |
- |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2019-12-26 |
4 |
S |
$18.60 |
$200,880 |
I/I |
(10,800) |
40,200 |
0 |
- |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2020-01-09 |
4 |
S |
$19.50 |
$7,409,942 |
I/I |
(379,997) |
38,808 |
0 |
% |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2020-03-02 |
4 |
S |
$26.00 |
$48,729,278 |
I/I |
(1,874,203) |
0 |
0 |
% |
|
| CRYO |
American Cryostem Corpora... |
10% Owner |
– – • |
2007-06-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(842,504) |
389,432 |
0 |
- |
|
| DBTX |
Decibel Therapeutics, Inc... |
Director |
– • • |
2021-02-17 |
4 |
B |
$18.00 |
$29,999,988 |
I/I |
1,666,666 |
883,418 |
2.25 |
- |
|
| DBTX |
Decibel Therapeutics, Inc... |
Director |
– • • |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
I/I |
3,278,526 |
218,568 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Director |
– • • |
2021-07-16 |
4 |
B |
$6.00 |
$9,999,996 |
I/I |
1,666,666 |
1,666,666 |
2.25 |
- |
|
| FUSN |
Fusion Pharmaceuticals In... |
Director |
– • – |
2020-06-30 |
4 |
B |
$17.00 |
$15,266,000 |
I/I |
898,000 |
192,100 |
2.1 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Director |
– • – |
2020-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,224,770 |
2,224,770 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
|
• • • |
2020-12-02 |
4 |
B |
$20.00 |
$15,000,000 |
I/I |
750,000 |
450,000 |
0.01 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
|
• • • |
2020-12-07 |
4 |
A |
$0.00 |
$0 |
I/I |
3,097,929 |
84,599 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Director |
– • – |
2022-02-11 |
4 |
B |
$10.22 |
$1,594,320 |
I/I |
156,000 |
3,469,330 |
2.1 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Director |
– • – |
2022-02-14 |
4 |
B |
$9.89 |
$305,486 |
I/I |
30,700 |
3,500,030 |
2.1 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Director |
– • – |
2022-02-15 |
4 |
B |
$9.96 |
$89,640 |
I/I |
9,000 |
3,509,030 |
2.1 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Director |
– • • |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
I/I |
1,100,000 |
550,000 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Director |
– • • |
2023-04-28 |
4 |
B |
$2.55 |
$894,410 |
I/I |
350,749 |
610,997 |
2.25 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Director |
– • • |
2023-05-01 |
4 |
B |
$2.62 |
$1,876,331 |
I/I |
716,157 |
735,542 |
2.25 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Director |
– • • |
2023-05-02 |
4 |
B |
$2.67 |
$903,160 |
I/I |
338,262 |
794,368 |
2.25 |
- |
|
58 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
